Trinity Biotech PLC SEC filings TRIB

Trinity Biotech PLC has 500 filings in SEC EDGAR's recent list, going back to Sep 9, 1996. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 5, 2026. The company's fiscal year ends on December 31.

Trinity Biotech PLC SEC filings
Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) May 4, 2026 —
3 Initial insider ownership Apr 8, 2026 Mar 18, 2026
3/A Filing Apr 8, 2026 Mar 18, 2026
3 Initial insider ownership Apr 3, 2026 Mar 18, 2026
3 Initial insider ownership Apr 3, 2026 Mar 18, 2026
3 Initial insider ownership Apr 3, 2026 Mar 18, 2026
3 Initial insider ownership Apr 3, 2026 Mar 18, 2026
SCHEDULE 13G Ownership over 5% (passive) Mar 6, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 26, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 23, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 15, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 10, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 4, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 24, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 25, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 14, 2025 —
SCHEDULE 13D Ownership over 5% (active) Dec 26, 2024 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 19, 2024 —
SC 13D/A Amended ownership over 5% (active) Nov 14, 2024 —
SC 13D/A Amended ownership over 5% (active) May 1, 2024 —
SC 13D Ownership over 5% (active) Feb 9, 2024 —
SC 13D/A Amended ownership over 5% (active) Jan 2, 2024 —
SC 13D/A Amended ownership over 5% (active) Jan 2, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2023 —
SC 13D Ownership over 5% (active) Dec 8, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 11, 2022 —
SC 13G Ownership over 5% (passive) Feb 4, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 16, 2021 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2021 —
SC 13G Ownership over 5% (passive) Feb 10, 2021 —
SC 13G/A Amended ownership over 5% (passive) Sep 4, 2020 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2020 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2020 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2020 —
SC 13G/A Amended ownership over 5% (passive) Jul 8, 2019 —
SC 13G Ownership over 5% (passive) May 3, 2019 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2019 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2019 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2019 —
SC 13G/A Amended ownership over 5% (passive) Dec 10, 2018 —
SC 13G Ownership over 5% (passive) Sep 17, 2018 —
SC 13G/A Amended ownership over 5% (passive) Apr 9, 2018 —
SC 13G/A Amended ownership over 5% (passive) Feb 15, 2018 —
SC 13G Ownership over 5% (passive) Feb 14, 2018 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2018 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2018 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2018 —
SC 13G/A Amended ownership over 5% (passive) Feb 8, 2018 —
SC 13G/A Amended ownership over 5% (passive) Feb 2, 2018 —
SC 13G/A Amended ownership over 5% (passive) Aug 4, 2017 —
SC 13G/A Amended ownership over 5% (passive) May 10, 2017 —
SC 13G Ownership over 5% (passive) Mar 15, 2017 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2017 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2017 —
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2017 —
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2017 —
SC 13G/A Amended ownership over 5% (passive) Feb 2, 2017 —
SC 13G Ownership over 5% (passive) Nov 2, 2016 —
SC 13G Ownership over 5% (passive) Feb 16, 2016 —
SC 13G Ownership over 5% (passive) Feb 12, 2016 —
SC 13G Ownership over 5% (passive) Feb 9, 2016 —
SC 13G/A Amended ownership over 5% (passive) Feb 5, 2016 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2015 —
SC 13G/A Amended ownership over 5% (passive) May 12, 2014 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2014 —
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2014 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2013 —
SC 13G Ownership over 5% (passive) Feb 14, 2013 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2013 —
SC 13G/A Amended ownership over 5% (passive) Feb 5, 2013 —
SC 13G Ownership over 5% (passive) Jan 28, 2013 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2012 —
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2012 —
SC 13G/A Amended ownership over 5% (passive) Jan 30, 2012 —
SC 13G Ownership over 5% (passive) Nov 14, 2011 —
SC 13G/A Amended ownership over 5% (passive) Oct 7, 2011 —
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2011 —
SC 13G/A Amended ownership over 5% (passive) Feb 8, 2011 —
SC 13G/A Amended ownership over 5% (passive) Apr 12, 2010 —
SC 13G Ownership over 5% (passive) Feb 10, 2010 —
SC 13G Ownership over 5% (passive) Feb 5, 2010 —
SC 13G/A Amended ownership over 5% (passive) Jan 12, 2009 —
SC 13G Ownership over 5% (passive) Dec 22, 2008 —
SC 13D Ownership over 5% (active) Oct 17, 2008 —
SC 13G Ownership over 5% (passive) May 7, 2008 —
SC 13G Ownership over 5% (passive) Jan 9, 2008 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2005 —
SC 13G/A Amended ownership over 5% (passive) Mar 8, 2004 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2004 —
SC 13G Ownership over 5% (passive) Sep 16, 2003 —
SC 13G Ownership over 5% (passive) Jan 8, 2003 —
SC 13D/A Amended ownership over 5% (active) Dec 9, 1996 —
SC 13D Ownership over 5% (active) Sep 9, 1996 —

Showing 94 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
TRIB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Ireland
Headquarters
Wicklow
SEC filer status
Non-accelerated filer
SEC CIK
888721

Other In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.